Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Harmony Biosciences Hldgs Analyst Ratings and Price Targets | NASDAQ:HRMY | Benzinga
Harmony Biosciences Holdings Inc has a consensus price target of $50.4 based on the ratings of 15 analysts. The high is $70 issued by HC Wainwright & Co. on April 8, 2025. The low is $28 issued by Goldman Sachs on January 9, 2024. The 3 most-recent analyst ratings were released by Oppenheimer, Mizuho, and Needham on June 2, 2025, May 15, 2025, and May 7, 2025, respectively. With an average price target of $52.67 between Oppenheimer, Mizuho, and Needham, there's an implied 45.97% upside for Harmony Biosciences Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Mizuho
Needham
UBS
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for Harmony Biosciences Hldgs
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/02/2025 | Buy Now | 69.07% | Oppenheimer | Andreas Argyrides71% | → $61 | Assumes | → Outperform | Get Alert |
| 05/15/2025 | Buy Now | 33.04% | Mizuho | Graig Suvannavejh52% | $44 → $48 | Maintains | Outperform | Get Alert |
| 05/07/2025 | Buy Now | 35.81% | Needham | Ami Fadia60% | $49 → $49 | Reiterates | Buy → Buy | Get Alert |
| 05/06/2025 | Buy Now | 35.81% | Needham | Ami Fadia60% | $49 → $49 | Reiterates | Buy → Buy | Get Alert |
| 04/28/2025 | Buy Now | 33.04% | UBS | Ashwani Verma49% | $55 → $48 | Maintains | Buy | Get Alert |
| 04/10/2025 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2025 | Buy Now | 94.01% | HC Wainwright & Co. | Patrick Trucchio51% | $70 → $70 | Reiterates | Buy → Buy | Get Alert |
| 04/08/2025 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 03/18/2025 | Buy Now | 21.95% | Mizuho | Graig Suvannavejh52% | $42 → $44 | Maintains | Outperform | Get Alert |
| 02/27/2025 | Buy Now | 94.01% | HC Wainwright & Co. | Patrick Trucchio51% | $75 → $70 | Maintains | Buy | Get Alert |
| 02/26/2025 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 02/25/2025 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2025 | Buy Now | 16.41% | Mizuho | Graig Suvannavejh52% | $52 → $42 | Maintains | Outperform | Get Alert |
| 02/19/2025 | Buy Now | 107.87% | HC Wainwright & Co. | Patrick Trucchio51% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 02/19/2025 | Buy Now | 38.58% | Needham | Ami Fadia60% | $52 → $50 | Maintains | Buy | Get Alert |
| 02/11/2025 | Buy Now | 52.44% | Deutsche Bank | David Hoang41% | → $55 | Initiates | → Buy | Get Alert |
| 01/27/2025 | Buy Now | 107.87% | HC Wainwright & Co. | Patrick Trucchio51% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 01/16/2025 | Buy Now | 107.87% | HC Wainwright & Co. | Patrick Trucchio51% | $75 → $75 | Reiterates | Buy → Buy | Get Alert |
| 01/13/2025 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 12/17/2024 | Buy Now | 107.87% | HC Wainwright & Co. | Patrick Trucchio51% | → $75 | Initiates | → Buy | Get Alert |
| 10/30/2024 | Buy Now | 60.75% | Cantor Fitzgerald | Charles Duncan69% | $51 → $58 | Maintains | Overweight | Get Alert |
| 10/30/2024 | Buy Now | 63.53% | Oppenheimer | Francois Brisebois40% | $56 → $59 | Reiterates | Outperform → Outperform | Get Alert |
| 10/30/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 10/29/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 10/10/2024 | Buy Now | 10.86% | Raymond James | Danielle Brill43% | → $40 | Reinstates | → Outperform | Get Alert |
| 10/10/2024 | Buy Now | 44.12% | Mizuho | Graig Suvannavejh52% | $42 → $52 | Maintains | Outperform | Get Alert |
| 10/02/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/24/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/12/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 09/10/2024 | Buy Now | 55.21% | UBS | Ashwani Verma49% | → $56 | Initiates | → Buy | Get Alert |
| 08/08/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 08/06/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 06/25/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 06/24/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $52 → $52 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2024 | Buy Now | 33.04% | Citigroup | David Hoang41% | → $48 | Initiates | → Buy | Get Alert |
| 05/01/2024 | Buy Now | 44.12% | Needham | Ami Fadia60% | $50 → $52 | Maintains | Buy | Get Alert |
| 04/30/2024 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 04/12/2024 | Buy Now | 35.81% | Cantor Fitzgerald | Charles Duncan69% | $49 → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 04/11/2024 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 04/09/2024 | Buy Now | 38.58% | Needham | Ami Fadia60% | $50 → $50 | Reiterates | Buy → Buy | Get Alert |
| 03/28/2024 | Buy Now | 35.81% | Cantor Fitzgerald | Charles Duncan69% | $49 → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 02/27/2024 | Buy Now | 10.86% | Mizuho | Graig Suvannavejh52% | $42 → $40 | Maintains | Buy | Get Alert |
| 02/23/2024 | Buy Now | 35.81% | Cantor Fitzgerald | Charles Duncan69% | $49 → $49 | Reiterates | Overweight → Overweight | Get Alert |
| 02/23/2024 | Buy Now | 38.58% | Needham | Ami Fadia60% | $53 → $50 | Maintains | Buy | Get Alert |
| 02/22/2024 | Buy Now | 46.9% | Needham | Ami Fadia60% | $53 → $53 | Reiterates | Buy → Buy | Get Alert |
| 02/16/2024 | Buy Now | 16.41% | Mizuho | Graig Suvannavejh52% | $33 → $42 | Maintains | Buy | Get Alert |
| 01/09/2024 | Buy Now | -22.39% | Goldman Sachs | Corinne Jenkins47% | $25 → $28 | Maintains | Sell | Get Alert |
| 01/02/2024 | Buy Now | -16.85% | B of A Securities | Jason Gerberry69% | → $30 | Downgrade | Neutral → Underperform | Get Alert |
| 11/01/2023 | Buy Now | 46.9% | Needham | Ami Fadia60% | → $53 | Reiterates | Buy → Buy | Get Alert |
| 11/01/2023 | Buy Now | -25.17% | Raymond James | Danielle Brill43% | $26 → $27 | Maintains | Outperform | Get Alert |
| 10/16/2023 | Buy Now | 16.41% | Piper Sandler | David Amsellem73% | $72 → $42 | Maintains | Overweight | Get Alert |
| 10/16/2023 | Buy Now | 46.9% | Needham | Ami Fadia60% | $66 → $53 | Maintains | Buy | Get Alert |
| 10/16/2023 | Buy Now | -27.94% | Raymond James | Danielle Brill43% | $58 → $26 | Maintains | Outperform | Get Alert |
| 10/04/2023 | Buy Now | 49.67% | Mizuho | Graig Suvannavejh52% | → $54 | Reiterates | Buy → Buy | Get Alert |
| 09/26/2023 | Buy Now | -14.08% | Goldman Sachs | Corinne Jenkins47% | $40 → $31 | Maintains | Sell | Get Alert |
| 09/25/2023 | Buy Now | -14.08% | Goldman Sachs | Corinne Jenkins47% | $40 → $31 | Downgrade | Neutral → Sell | Get Alert |
| 09/22/2023 | Buy Now | 82.93% | Needham | Ami Fadia60% | → $66 | Reiterates | Buy → Buy | Get Alert |
| 09/19/2023 | Buy Now | 49.67% | Mizuho | Graig Suvannavejh52% | $54 → $54 | Maintains | Buy | Get Alert |
| 09/07/2023 | Buy Now | 63.53% | Berenberg | Caroline Palomeque59% | → $59 | Initiates | → Buy | Get Alert |
| 08/29/2023 | Buy Now | 49.67% | Mizuho | Graig Suvannavejh52% | → $54 | Reiterates | Buy → Buy | Get Alert |
| 08/22/2023 | Buy Now | 107.87% | Cantor Fitzgerald | Charles Duncan69% | → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 08/15/2023 | Buy Now | 82.93% | Needham | Ami Fadia60% | → $66 | Reiterates | Buy → Buy | Get Alert |
| 08/03/2023 | Buy Now | 49.67% | Mizuho | Graig Suvannavejh52% | $60 → $54 | Maintains | Buy | Get Alert |
| 08/02/2023 | Buy Now | 82.93% | Needham | Ami Fadia60% | → $66 | Reiterates | Buy → Buy | Get Alert |
| 08/02/2023 | Buy Now | 60.75% | Raymond James | Danielle Brill43% | $62 → $58 | Maintains | Outperform | Get Alert |
| 08/01/2023 | Buy Now | 82.93% | Needham | Ami Fadia60% | → $66 | Reiterates | Buy → Buy | Get Alert |
| 06/23/2023 | Buy Now | 107.87% | Cantor Fitzgerald | Charles Duncan69% | $75 → $75 | Reiterates | Overweight → Overweight | Get Alert |
| 06/02/2023 | Buy Now | 85.7% | Needham | Ami Fadia60% | → $67 | Reiterates | Buy → Buy | Get Alert |
| 05/30/2023 | Buy Now | 85.7% | Needham | Ami Fadia60% | → $67 | Reiterates | → Buy | Get Alert |
| 05/26/2023 | Buy Now | 91.24% | Oppenheimer | Francois Brisebois40% | → $69 | Reiterates | Outperform → Outperform | Get Alert |
| 05/03/2023 | Buy Now | 107.87% | Cantor Fitzgerald | Charles Duncan69% | $71 → $75 | Maintains | Overweight | Get Alert |
| 05/03/2023 | Buy Now | 85.7% | Needham | Ami Fadia60% | → $67 | Reiterates | → Buy | Get Alert |
| 04/20/2023 | Buy Now | -2.99% | B of A Securities | Jason Gerberry69% | → $35 | Initiates | → Neutral | Get Alert |
| 04/17/2023 | Buy Now | 85.7% | Needham | Ami Fadia60% | → $67 | Reiterates | → Buy | Get Alert |
| 03/30/2023 | Buy Now | 66.3% | Mizuho | Graig Suvannavejh52% | → $60 | Reiterates | → Buy | Get Alert |
| 03/29/2023 | Buy Now | 66.3% | Mizuho | Graig Suvannavejh52% | → $60 | Reiterates | → Buy | Get Alert |
| 02/23/2023 | Buy Now | 19.18% | Goldman Sachs | Corinne Jenkins47% | $49 → $43 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | 19.18% | Goldman Sachs | Corinne Jenkins47% | $49 → $43 | Maintains | Neutral | Get Alert |
| 02/22/2023 | Buy Now | 66.3% | Mizuho | Graig Suvannavejh52% | $70 → $60 | Maintains | Buy | Get Alert |
| 02/22/2023 | Buy Now | 85.7% | Needham | Ami Fadia60% | $70 → $67 | Maintains | Buy | Get Alert |
| 02/21/2023 | Buy Now | 94.01% | Needham | Ami Fadia60% | → $70 | Reiterates | → Buy | Get Alert |
| 01/04/2023 | Buy Now | 94.01% | Piper Sandler | David Amsellem73% | $62 → $70 | Maintains | Overweight | Get Alert |
| 11/08/2022 | Buy Now | 94.01% | Mizuho | Graig Suvannavejh52% | $60 → $70 | Maintains | Buy | Get Alert |
| 11/03/2022 | Buy Now | 71.84% | Raymond James | Danielle Brill43% | $60 → $62 | Maintains | Outperform | Get Alert |
| 11/02/2022 | Buy Now | 80.16% | Needham | Ami Fadia60% | $60 → $65 | Maintains | Buy | Get Alert |
| 10/21/2022 | Buy Now | 41.35% | Goldman Sachs | Corinne Jenkins47% | $58 → $51 | Maintains | Neutral | Get Alert |
| 10/14/2022 | Buy Now | 69.07% | Jefferies | Chris Howerton62% | $57 → $61 | Upgrade | Hold → Buy | Get Alert |
| 08/04/2022 | Buy Now | 66.3% | Mizuho | Graig Suvannavejh52% | $64 → $60 | Maintains | Buy | Get Alert |
| 08/03/2022 | Buy Now | 85.7% | Oppenheimer | Francois Brisebois40% | $62 → $67 | Maintains | Outperform | Get Alert |
| 08/03/2022 | Buy Now | 57.98% | Jefferies | Chris Howerton62% | → $57 | Downgrade | Buy → Hold | Get Alert |
| 08/03/2022 | Buy Now | 66.3% | Raymond James | Danielle Brill43% | $58 → $60 | Maintains | Outperform | Get Alert |
| 07/13/2022 | Buy Now | 52.44% | Goldman Sachs | Corinne Jenkins47% | → $55 | Downgrade | Buy → Neutral | Get Alert |
| 07/07/2022 | Buy Now | 77.38% | Mizuho | Graig Suvannavejh52% | → $64 | Initiates | → Buy | Get Alert |
| 06/29/2022 | Buy Now | 71.84% | Oppenheimer | Francois Brisebois40% | $55 → $62 | Maintains | Outperform | Get Alert |
FAQ
What is the target price for Harmony Biosciences Hldgs (HRMY) stock?
The latest price target for Harmony Biosciences Hldgs (NASDAQ:HRMY) was reported by Oppenheimer on June 2, 2025. The analyst firm set a price target for $61.00 expecting HRMY to rise to within 12 months (a possible 72.22% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Harmony Biosciences Hldgs (HRMY)?
The latest analyst rating for Harmony Biosciences Hldgs (NASDAQ:HRMY) was provided by Oppenheimer, and Harmony Biosciences Hldgs their outperform rating.
When was the last upgrade for Harmony Biosciences Hldgs (HRMY)?
The last upgrade for Harmony Biosciences Holdings Inc happened on October 14, 2022 when Jefferies raised their price target to $61. Jefferies previously had a hold for Harmony Biosciences Holdings Inc.
When was the last downgrade for Harmony Biosciences Hldgs (HRMY)?
The last downgrade for Harmony Biosciences Holdings Inc happened on January 2, 2024 when B of A Securities changed their price target from N/A to $30 for Harmony Biosciences Holdings Inc.
When is the next analyst rating going to be posted or updated for Harmony Biosciences Hldgs (HRMY)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harmony Biosciences Hldgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harmony Biosciences Hldgs was filed on June 2, 2025 so you should expect the next rating to be made available sometime around June 2, 2026.
Is the Analyst Rating Harmony Biosciences Hldgs (HRMY) correct?
While ratings are subjective and will change, the latest Harmony Biosciences Hldgs (HRMY) rating was a with a price target of $0.00 to $61.00. The current price Harmony Biosciences Hldgs (HRMY) is trading at is $35.42, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
